In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing

BACKGROUND: In November 2021, variant B.1.1.529 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified by the World Health Organization (WHO) and designated Omicron. Omicron is characterized by a high number of mutations, thirty-two in total, making it more transmissible than...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Eslam A. R., Abdel-Rahman, Islam M., Zaki, Magdi E. A., Al-Khdhairawi, Ahmad, Abdelhamid, Mahmoud M., Alqaisi, Ahmad M., Rahim, Lyana binti Abd, Abu-Hussein, Bilal, El-Sheikh, Azza A. K., Abdelwahab, Sayed F., Hassan, Heba Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939377/
https://www.ncbi.nlm.nih.gov/pubmed/36808314
http://dx.doi.org/10.1007/s00894-023-05457-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939377/
https://www.ncbi.nlm.nih.gov/pubmed/36808314
http://dx.doi.org/10.1007/s00894-023-05457-z

Ejemplares similares